• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

GENE THERAPY FOR EXPERIMENTAL GLIOMAS USING TUMOR SUPPRESSOR GENES (P53, P16).

Research Project

Project/Area Number 08457368
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Cerebral neurosurgery
Research InstitutionOKAYAMA UNIVERSITY

Principal Investigator

FURUTA Tomohisa  OKAYAMA UNIVERSITY HOSPITAL,ASSOCIATE , PROFESSOR, 医学部附属病院, 助教授 (30181457)

Co-Investigator(Kenkyū-buntansha) ONO Yasuhiro  OKAYAMA UNIVERSITY MEDICAL SCHOOL,ASSISTANT, 医学部, 助手 (40294409)
TAMIYA Takashi  OKAYAMA UNIVERSITY HOSPITAL,LECTURER, 医学部附属病院, 講師 (50252953)
MATSUMOTO Kengo  OKAYAMA UNIVERSITY MEDICAL SCHOOL,ASSOCIATE PROFESSOR, 医学部, 助教授 (10190521)
国塩 勝三  岡山大学, 医学部・附属病院, 助手 (50273983)
Project Period (FY) 1996 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥6,200,000 (Direct Cost: ¥6,200,000)
Fiscal Year 1998: ¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1997: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 1996: ¥2,600,000 (Direct Cost: ¥2,600,000)
Keywordsp53 / p16 / p21 / p27 / tumor suppressor gene / gene therapy / adenovirus vector / brain tumors / p53 / p16 / p27 / p21 / tumor suppressor gene / gene therapy / adenovirus vector / brain tumor / tumor suppresor gene / glioma cells / qlioma cells / adenovitrus vector
Research Abstract

Recently, cell cycle regulators and tumor suppressor genes have been shown to be disrupted in human cancers. We therefore investigated homozygous CDKN2/p16 deletions, p53 gene and protein status, and expression of p21, p27^< Kipl> and cyclin E proteins in astrocytomas and compared to the cell cycle or prognosis of patients with astrocytomas.
In astrocytomas grade 3 and 4, Ki-67 labeling indices were significantly higher in tumors with CDKN2/p16 deletions than in those without deletions. These results suggest that homozygous CDKN2/p16 deletions in high-grade astrocytomas may have a more deleterious effect on tumor proliferation than the other aberrations in cell cycle control pathways.
Neither p53 nor p21 status correlated with proliferation indices, as assessed by Ki-67. p53 alterations are thought to be more related to tumor initiation than to tumor malignancy.
High expression of cyclin E and low expression of p27^< Kipl> was related with worse prognosis of patients with astrocytoma.
These findings demonstrate that analyses of cell cycle regulators and tumor suppressor genes, such as p16, p21, p27^< Kipl> and p53, are potentially useful in classifying astrocytomas by histological or biological malignancy and in predicting the prognosis of patients with astrocytomas, and suggest the possibility of gene therapy with adenovirus vectors expressing cell cycle regulators and tumor suppressor genes, such as p16, p21, p27^< Kipl> and p53.

Report

(4 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • 1996 Annual Research Report
  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] Takashi Tamiya: "Escherichia coli gpt gene sensitizes rat glioma cells to killing by 6 thioxanthine or 6-thioguanine" Cancer Gene Therapy. 3・3. 155-162 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yasuhiro Ono: "Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices" Journal of Neuropathology and Experimental Neurology. 55-10. 1026-1031 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yasuhiro Ono: "Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression." Acta Neuropathologica. 94-1. 21-27 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yasuhiro Ono: "Regression of experimental brain tumors with 6-thioxanthine and Esherichia coli gpt gene therapy." Human Gene Therapy. 8-17. 2043-2055 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Shinichiro Mizumatsu: "Expression of cell-cycle regulator p27^<Kipt> correlates with survival in patients with astrocytoma." Clinical Cancer Research. 5-3. 551-557 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Tomotsugu Ichikawa: "In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus." Cancer Gene Therapy. (in press). (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Tamiya T,Ono Y,Wei MX,Mroz PJ,Moolten FL,Chiocca EA: "Escherichia coli gpt gene sensitizes rat glioma cells to killing by 6-thioxanthine or 6-thioguanine." Cancer Gene Terapy. 3. 155-162 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ono Y,Tamiya T,Ichikawa T,Kunishio K,Matsumoto K,Furuta T,Ohmoto T,Ueki K,Louis DN: "Malignant astrocytomas with Homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices." J Neuropathol Exp Neural. 55. 1026-1031 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ono Y,Tamiya T,Ichikawa T,Matsumoto K,Furuta T,Ohmoto T,Akiyama K,Seki S,Ueki K,Louis DN: "Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression." Acta Neuropathol. 94 (1). 21-27 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ono Y,Wei MX,Ikeda K,Tamiya T,Harsh IV GR,Chioca EA: "Regression of experimental brain tumors with 6-thioxanthine and Esherichia coli gpt gene therapy." Human Gene Ther. 8 (17). 2043-2055 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Mizumatsu S,Tamiya T,Ono Y,Abe T,Matsumoto K,Furuta T,Ohmoto T: "Expression of cell-cycle regulator p27^<Kipl> correlates with survival in patients with astrocytoma." Clinical Cancer Research. 5 (3). 551-557

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ichikawa T,Tamiya T,Adachi Y,Ono Y,Matsumoto K,Furuta T,Ohmoto T: "In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus." Cancer Gene Therapy. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 市川智継: "Adenovirus vectorによる実験的脳腫瘍への遺伝子導入の検討" 脳と神経. 50・8. 731-738 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Shinichiro Mizumatsu: "Expression of cell-cycle regulator p27^<Kip1> correlates with survival in patients with astrocytoma." Clinical Cancer Research. (in press). (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Tomotsugu Ichikawa: "In vivo efficacy and toxicity of 5-fluorocytosine / cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus." Cancer Gene Therapy. (in press). (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Yasuhiro Ono: "Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression." Acta Neuropathologica. 94・1. 21-27 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Yasuhiro Ono: "Regression of experimental brain tumors with 6-thioxanthine and Esherichia coli gpt gene therapy." Human Gene Therapy. 8・17. 2043-2055 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi